Answers are grounded in this paper and cite their sources.
Psoriasis is an inflammatory disease with both skin and joint manifestations.Focused biologics have been developed to target specific cytokines implicated in psoriasis and are becoming increasingly utilized.Recently, the advent of newer biologics, including IL-17, IL-12/IL-23, and IL-23 inhibitors, have garnered interest as promising treatments for psoriasis and other inflammatory conditions.Although IL-17 and IL-23 have been studied in the pathophysiology of psoriasis, they also play a central role in immunologic defenses, including those against fungi.Therefore, use of these interleukin inhibitors may theoretically impair the immune system against deep fungal infections.We reviewed the available literature investigating the risk for invasive fungal infections in patients treated with IL-17 and IL-23 inhibitors for psoriasis or other inflammatory conditions.Randomized controlled trials (RCTs), including extended trials and clinical trials, were reviewed, and we found that although there was a small number of patients who developed superficial candidiasis, there were no reports of invasive fungal disease.Although these results support the safety and the low risk for deep fungal infection with these biologics, caution is still warranted, as these medications are relatively new.Appropriate screening and management of fungal disease should still be practiced when utilizing these medications in the treatment of psoriasis and other inflammatory conditions.Cutis.2020;106:199-205. Psoriasis is a common chronic, multisystem, inflammatory disease with predominantly skin and joint manifestations that affects approximately 2% of the world's population. 1 It occurs in a variety of clinical forms, from a few well-demarcated, erythematous plaques with a silvery scale to involvement of almost the entire body surface area.Beyond the debilitating physical ailments of the disease, psoriasis also may have psychosocial effects on quality of life. 2 The pathogenesis of psoriasis is not fully understood but represents a complex multifactorial disease with both immune-mediated and genetic components.Characterized by hyperplasia of epidermal keratinocytes, psoriasis is shown to be mediated by infiltration of T-cell lymphocytes with an increase of various inflammatory cytokines, including tumor necrosis factor (TNF) α. 3 More recently, interactions of helper T cells (T H 17) via IL-17 and IL-23 have been supported to play a major role in the pathogenesis of psoriasis.4,5 With the growing understanding of the pathophysiology of psoriasis, focused biologics have been developed Risk for Deep Fungal Infections During IL-17 and IL-23 Inhibitor Therapy for Psoriasis
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: